Noninvasive Gene Expression Test for Melanoma Cuts Costs
From - Diagnostic Testing & Emerging Technologies The noninvasive pigmented lesion assay (PLA; DermTech) reduces costs compared to the current standard of care for diagnostic workup of pigmented skin lesions suggestive of… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article